Sarah Pearson

1.4k total citations
15 papers, 486 citations indexed

About

Sarah Pearson is a scholar working on Oncology, General Health Professions and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Sarah Pearson has authored 15 papers receiving a total of 486 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 3 papers in General Health Professions and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Sarah Pearson's work include Colorectal Cancer Surgical Treatments (3 papers), Asthma and respiratory diseases (3 papers) and Childhood Cancer Survivors' Quality of Life (2 papers). Sarah Pearson is often cited by papers focused on Colorectal Cancer Surgical Treatments (3 papers), Asthma and respiratory diseases (3 papers) and Childhood Cancer Survivors' Quality of Life (2 papers). Sarah Pearson collaborates with scholars based in United Kingdom, United States and Australia. Sarah Pearson's co-authors include W. Thomas Boyce, Andrew Weaver, Mark Larsen, Lionel Tarassenko, Oliver Gibson, Annie Young, Nick Townsend, Joshua Smith, Graham Roberts and David Kerr and has published in prestigious journals such as Journal of Clinical Oncology, The Lancet Oncology and Journal of Allergy and Clinical Immunology.

In The Last Decade

Sarah Pearson

14 papers receiving 474 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sarah Pearson United Kingdom	9	158	98	80	76	72	15	486
Liza Takiya United States	15	51 0.3×	66 0.7×	45 0.6×	89 1.2×	22 0.3×	47	888
Johan Lyth Sweden	16	370 2.3×	72 0.7×	38 0.5×	25 0.3×	69 1.0×	46	640
Giuseppina Gallucci Italy	10	121 0.8×	18 0.2×	81 1.0×	22 0.3×	81 1.1×	31	525
Olaf Schoffer Germany	14	195 1.2×	137 1.4×	21 0.3×	9 0.1×	98 1.4×	59	709
Hiroki Tateno Japan	15	89 0.6×	52 0.5×	267 3.3×	26 0.3×	385 5.3×	29	731
A.H. Liu United States	10	153 1.0×	81 0.8×	17 0.2×	15 0.2×	26 0.4×	38	515
Margaret M. Farrell United States	10	157 1.0×	154 1.6×	41 0.5×	20 0.3×	25 0.3×	15	612
Nicole Walker Australia	13	44 0.3×	84 0.9×	29 0.4×	8 0.1×	56 0.8×	32	682
Nasrin Fouladi Iran	11	192 1.2×	60 0.6×	15 0.2×	19 0.3×	103 1.4×	23	457
K Malottki United Kingdom	11	59 0.4×	30 0.3×	52 0.7×	10 0.1×	86 1.2×	17	725

Countries citing papers authored by Sarah Pearson

Since Specialization

Citations

This map shows the geographic impact of Sarah Pearson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Pearson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Pearson more than expected).

Fields of papers citing papers by Sarah Pearson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Pearson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Pearson. The network helps show where Sarah Pearson may publish in the future.

Co-authorship network of co-authors of Sarah Pearson

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Pearson. A scholar is included among the top collaborators of Sarah Pearson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Pearson. Sarah Pearson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Hanna, Catherine, Andrew Briggs, Andrea Harkin, et al.. (2021). Three Versus Six Months of Adjuvant Doublet Chemotherapy for Patients With Colorectal Cancer: A Multi-Country Cost-Effectiveness and Budget Impact Analysis. Clinical Colorectal Cancer. 20(3). 236–244. 2 indexed citations

Saunders, Mark, James Paul, Gordon Brown, et al.. (2018). SCOT: Tumor sidedness and the influence of chemotherapy duration on DFS.. Journal of Clinical Oncology. 36(4_suppl). 558–558.

Kerr, Rachel, Sharon Love, Eva Segelov, et al.. (2016). Adjuvant capecitabine plus bevacizumab versus capecitabine alone in patients with colorectal cancer (QUASAR 2): an open-label, randomised phase 3 trial. The Lancet Oncology. 17(11). 1543–1557. 95 indexed citations

Zolkipli, Zaraquiza, Graham Roberts, Victoria Cornelius, et al.. (2015). Randomized controlled trial of primary prevention of atopy using house dust mite allergen oral immunotherapy in early childhood. Journal of Allergy and Clinical Immunology. 136(6). 1541–1547.e11. 83 indexed citations

Legg, Julian, et al.. (2015). The validity and acceptability of a text-based monitoring system for pediatric asthma studies. Pediatric Pulmonology. 51(1). 5–12. 10 indexed citations

Zolkipli, Zaraquiza, Graham Roberts, Ramesh Kurukulaaratchy, et al.. (2014). O24 ‐ Mite allergy prevention study. Clinical and Translational Allergy. 4(S1). 1 indexed citations

Nicum, Shibani, Claire Brooks, Rose Wharton, et al.. (2013). Phase II clinical trial of six mercaptopurine (6MP) and methotrexate in patients with BRCA-defective tumors.. Journal of Clinical Oncology. 31(15_suppl). TPS5615–TPS5615. 1 indexed citations

Kennedy, Robin H., Anne Francis, Susan Dutton, et al.. (2012). EnROL: A multicentre randomised trial of conventional versus laparoscopic surgery for colorectal cancer within an enhanced recovery programme. BMC Cancer. 12(1). 181–181. 32 indexed citations

Ferry, D., Wasat Mansoor, J N Thompson, et al.. (2012). Phase III Multi-Centre, Randomised, Double-Blind, Placebo-Controlled Trial of Gefitinib versus Placebo in Esophageal Cancer Progressing after Chemotherapy, COG (Cancer Oesophagus Gefitinib). Annals of Oncology. 23. ixe12–ixe12. 13 indexed citations

10.

Larsen, Mark, Annie Young, Sarah Pearson, et al.. (2008). Chemotherapy side-effect management using mobile phones. PubMed. 2008. 5152–5155. 33 indexed citations

11.

Weaver, Andrew, Annie Young, Nick Townsend, et al.. (2007). Application of mobile phone technology for managing chemotherapy-associated side-effects. Annals of Oncology. 18(11). 1887–1892. 121 indexed citations

12.

Pearson, Sarah, Abbey Alkon, Marsha Treadwell, et al.. (2005). Autonomic reactivity and clinical severity in children with sickle cell disease. Clinical Autonomic Research. 15(6). 400–407. 56 indexed citations

13.

Pearson, Sarah & W. Thomas Boyce. (2004). Consultation with the Specialist: Table.. Pediatrics in Review. 25(10). 345–349. 34 indexed citations

14.

Pearson, Sarah & W. Thomas Boyce. (2004). Consultation with the Specialist. Pediatrics in Review. 25(10). 345–349. 4 indexed citations

15.

Pearson, Sarah, et al.. (2003). The role of preoperative state-anxiety in the determination of intraoperative neuroendocrine responses and recovery. Journal of Psychosomatic Research. 55(2). 155–156. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact